BBA
VIRX
Baker Bros. Advisors’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-53,066
| Closed | -$106K | – | 134 |
|
|
2020
Q4 | $106K | Hold |
53,066
| – | – | ﹤0.01% | 125 |
|
|
2020
Q3 | $66K | Sell |
53,066
-503,599
| -90% | -$626K | ﹤0.01% | 120 |
|
|
2020
Q2 | $147K | Hold |
556,665
| – | – | ﹤0.01% | 113 |
|
|
2020
Q1 | $231K | Hold |
556,665
| – | – | ﹤0.01% | 108 |
|
|
2019
Q4 | $188K | Hold |
556,665
| – | – | ﹤0.01% | 99 |
|
|
2019
Q3 | $401K | Hold |
556,665
| – | – | ﹤0.01% | 105 |
|
|
2019
Q2 | $405K | Hold |
556,665
| – | – | ﹤0.01% | 100 |
|
|
2019
Q1 | $676K | Hold |
556,665
| – | – | ﹤0.01% | 93 |
|
|
2018
Q4 | $231K | Hold |
556,665
| – | – | ﹤0.01% | 92 |
|
|
2018
Q3 | $1.11M | Hold |
556,665
| – | – | 0.01% | 91 |
|
|
2018
Q2 | $1.18M | Hold |
556,665
| – | – | 0.01% | 105 |
|
|
2018
Q1 | $1.51M | Sell |
556,665
-185,000
| -25% | -$503K | 0.01% | 96 |
|
|
2017
Q4 | $2.74M | Hold |
741,665
| – | – | 0.02% | 93 |
|
|
2017
Q3 | $1.44M | Hold |
741,665
| – | – | 0.01% | 102 |
|
|
2017
Q2 | $2M | Hold |
741,665
| – | – | 0.02% | 87 |
|
|
2017
Q1 | $3.04M | Hold |
741,665
| – | – | 0.02% | 77 |
|
|
2016
Q4 | $2.69M | Hold |
741,665
| – | – | 0.03% | 83 |
|
|
2016
Q3 | $3.24M | Sell |
741,665
-3,708,335
| -83% | -$16.2M | 0.03% | 78 |
|
|
2016
Q2 | $2.44M | Hold |
4,450,000
| – | – | 0.03% | 91 |
|
|
2016
Q1 | $2.4M | Hold |
4,450,000
| – | – | 0.03% | 93 |
|
|
2015
Q4 | $3.99M | Buy |
4,450,000
+1,250,000
| +39% | +$1.12M | 0.03% | 85 |
|
|
2015
Q3 | $2.59M | Hold |
3,200,000
| – | – | 0.02% | 96 |
|
|
2015
Q2 | $9.63M | Hold |
3,200,000
| – | – | 0.08% | 65 |
|
|
2015
Q1 | $7.84M | Hold |
3,200,000
| – | – | 0.07% | 65 |
|
|
2014
Q4 | $8.16M | Buy |
+3,200,000
| New | +$8.16M | 0.08% | 55 |
|